Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLIGENIX, INC.SNGX · Entity 8067 | SVP and CFO | December 13, 2018 | December 14, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLIGENIX, INC.
Report date December 13, 2018 · Filed December 14, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.97 · Expires 2028-12-12 | Direct | 40,000 |
Reported balance
After 2018-12-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-12-13 · Grant · Acquired 40,000 · Balance 40,000 F1: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2018 Filed Dec 14, 2018 21:33 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001213900-18-017380 · ownership.xml · derivative · entry 1 Krumeich Karen R · CIK 0001334797 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-12-12 F1 · security: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018. F1 · derivative.exercise_date: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:16 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001213900-17-013089 · f4120717krumeich_soligenix.xml · derivative · entry 1 Krumeich Karen R · CIK 0001334797 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-12-06 F1 · security: The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017. F1 · derivative.exercise_date: The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:16 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-17-003323 · f4033117krumeich_soligenix.xml · derivative · entry 1 Krumeich Karen R · CIK 0001334797 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-30 F1 · security: The stock option vested immediately as to 5,000 shares and vests as to the remainder at a rate of 1,250 of the shares on each three (3) month anniversary of March 31, 2017. F1 · derivative.exercise_date: The stock option vested immediately as to 5,000 shares and vests as to the remainder at a rate of 1,250 of the shares on each three (3) month anniversary of March 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.